IP Library › Granted Patent US 11,959,109
Granted Patent B2
US 11,959,109 · App. 18/346,420 · Granted Apr 16, 2024

Recombinant Factor C and method for producing the same, and method for measuring endotoxin

Inventors: Hikaru Mizumura (Tokyo, JP); Toshio Oda (Tokyo, JP); Shun-ichiro Kawabata (Fukuoka, JP)
Assignee: SEIKAGAKU CORPORATION
C12N9/6408C12Y304/21069C12Y304/21084G01N33/56911G01N33/579G01N2333/96411
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,959,109
App. No.
18/346,420
Granted
Apr 16, 2024
Kind
B2
Abstract

A horseshoe crab Factor C protein having activity of Factor C, wherein the horseshoe crab is selected from Tachypleus tridentatus, Limulus polyphemus , and Carcinoscorpius rotundicauda , and wherein the horseshoe crab Factor C protein is produced through being recombinantly expressed from a Chinese Hamster Ovary (CHO) DG44 cell or HEK cell.

Claims (22)

1. A method for producing an endotoxin assay agent comprising a horseshoe crab Factor C, a horseshoe crab Factor B, and a horseshoe crab Pro-clotting enzyme, the method comprising:

expressing the horseshoe crab Factor C in a Chinese Hamster Ovary cell or a Human Embryonic Kidney cell as a host cell, secreting the horseshoe crab Factor C into an extracellular culture supernatant, and recovering the horseshoe crab Factor C in the culture supernatant, wherein the recovered horseshoe Factor C has activity of Factor C, and wherein the horseshoe crab Factor C is a Tachypleus tridentatus Factor C or a Limulus polyphemus Factor C,

expressing the horseshoe crab Factor B having activity of Factor B in a mammalian cell as a host cell,

expressing the horseshoe crab Pro-clotting enzyme in a mammalian cell as a host cell, and

producing an endotoxin assay agent comprising the horseshoe crab Factor C, the horseshoe crab Factor B, and the horseshoe crab Pro-clotting enzyme,

wherein the host cell for expressing the horseshoe crab Factor C, the host cell for expressing the horseshoe crab Factor B, and the host cell for expressing the horseshoe crab Pro-clotting enzyme may be the same or different.

2. The method according to claim 1 , wherein the mammalian cell expressing the Factor B is a Chinese Hamster Ovary cell or a Human Embryonic Kidney cell.

3. The method according to claim 1 , wherein the mammalian cell expressing the Pro-clotting enzyme is a Chinese Hamster Ovary cell or a Human Embryonic Kidney cell.

4. The method according to claim 1 , wherein the horseshoe crab for the Factor B and/or the horseshoe crab for the Pro-clotting enzyme is selected from the group consisting of Tachypleus tridentatus and Limulus polyphemus.

5. The method according to claim 1 , wherein the horseshoe crab Factor C contains (α-2,3)-linked terminal sialic acid in a greater amount, as compared with a corresponding Factor C protein recombinantly expressed using Sf9 as a host cell.

6. The method according to claim 1 , wherein the horseshoe crab Factor C has a molecular weight of 115 kDa to 130 kDa, as measured through SDS-PAGE under a nonreducing condition.

7. The method according to claim 1 , further comprising filtering the culture supernatant comprising the horseshoe crab Factor C.

8. The method according to claim 1 , wherein the endotoxin assay agent is formulated as a solid, a liquid, or a gel.

9. The method according to claim 1 , wherein the horseshoe crab Factor C, the horseshoe crab Factor B, and the horseshoe crab Pro-clotting enzyme are separately expressed in individually established host cells.

10. A method for measuring endotoxin in a test specimen, the method comprising

expressing a horseshoe crab Factor C in a Chinese Hamster Ovary cell or a Human Embryonic Kidney cell as a host cell, secreting the horseshoe crab Factor C into an extracellular culture supernatant, and recovering the horseshoe crab Factor C in the culture supernatant, wherein the recovered horseshoe Factor C has activity of Factor C, and wherein the horseshoe crab Factor C is a Tachypleus tridentatus Factor C or a Limulus polyphemus Factor C,

expressing a horseshoe crab Factor B having activity of Factor B in a mammalian cell as a host cell,

expressing a horseshoe crab Pro-clotting enzyme in a mammalian cell as a host cell,

producing an endotoxin assay agent comprising the horseshoe crab Factor C, the horseshoe crab Factor B, and the horseshoe crab Pro-clotting enzyme,

mixing the endotoxin assay agent and a test specimen, and

measuring progress of a cascade reaction,

wherein the host cell for expressing the horseshoe crab Factor C, the host cell for expressing the horseshoe crab Factor B, and the host cell for expressing the horseshoe crab Pro-clotting enzyme may be the same or different.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2025
From: MIZUMURA, HIKARU; ODA, TOSHIO; KAWABATA, SHUN-ICHIRO
To: SEIKAGAKU CORPORATION
Reel/Frame 071644/0258 →
Priority Claims (1)
JP 2012-269840 · Dec 10, 2012 · national
Continuity (5)
Continuation 17554128 · Dec 17, 2021
Continuation 16399386 · Apr 30, 2019
Continuation 15983725 · May 18, 2018
Continuation 14650767
Related Publication 20230357742A1 · Nov 9, 2023